Kronos Bio Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
Positive End-of-Phase 2 meeting with the FDA for entospletinib in newly diagnosed NPM1-mutated acute myeloid
Bio
Yokogawa Establishes Yokogawa Bio Frontier Inc. to Progress Biomass Resources Business enterprise
Bloomberg Scion of Billionaire Family members Hunts for Low-priced Belongings in Venezuela (Bloomberg) — The
Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update
Closed business combination with Panacea, yielding new public listing and strong cash position of approximately
JS Bio and Etta Biotech Advancing Strategic Partnership | Business enterprise & Finance
THOUSAND OAKS, Calif. & SHANGHAI–(Business WIRE)–Jan 17, 2021– Jianshun Biosciences Co., Ltd. (“JS Bio”) lately